Bixiye
P41-18 Update: Change to TPA Business
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 04, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2871 - 2880 ee natiijooyinka 3607
Bixiye
P46-17 Addition of Drug to the Self-Administered Oncology PA with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P10-18 Blue Cross Will Cease Mailing Certain Provider Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2018
Bixiye
P19R1-17 New Remittance Code: OA-45 for Purchased/Referred (PRC)-Eligible Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 24, 2017
Bixiye
P8-18 Changes to PA for Hip Arthroplasty, Hip Resurfacing and Knee Arthroplasty for Commercial and Government Programs Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2018
Bixiye
P78-17 Cotiviti to Perform Inpatient Claims Reviews
Taariikhda uu dhaqangalayo Barnaamijka: Des 12, 2017
Bixiye
P54-17 Clarification to Commercial Prior Authorization Requirements for Early Intensive Behavioral Intervention (EIBI)
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2017
Bixiye
P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2018
Bixiye
P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018